Amorepacific Future Growth

Future criteria checks 1/6

Amorepacific's earnings are forecast to decline at 12.5% per annum while its annual revenue is expected to grow at 13.5% per year. EPS is expected to decline by 9.5% per annum. Return on equity is forecast to be 8% in 3 years.

Key information

-12.5%

Earnings growth rate

-9.5%

EPS growth rate

Personal Products earnings growth	29.4%
Revenue growth rate	13.5%
Future return on equity	8.0%
Analyst coverage	Good
Last updated	14 Aug 2024

Recent future growth updates

Recent updates

Amorepacific Corporation's (KRX:090430) Share Price Is Still Matching Investor Opinion Despite 26% Slump

Aug 17

Does Amorepacific's (KRX:090430) Statutory Profit Adequately Reflect Its Underlying Profit?

Feb 14

Amorepacific Corporation (KRX:090430) Shares Could Be 30% Above Their Intrinsic Value Estimate

Jan 31

The Trends At Amorepacific (KRX:090430) That You Should Know About

Jan 18

Amorepacific Corporation's (KRX:090430) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

Jan 05

Is Amorepacific Corporation (KRX:090430) An Attractive Dividend Stock?

Dec 21

Amorepacific (KRX:090430) Seems To Use Debt Quite Sensibly

Dec 06

Could The Amorepacific Corporation (KRX:090430) Ownership Structure Tell Us Something Useful?

Nov 20

Earnings and Revenue Growth Forecasts

KOSE:A090430 - Analysts future estimates and past financials data (KRW Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2026	5,080,181	496,710	541,196	694,836	20
12/31/2025	4,647,704	424,370	484,463	611,303	24
12/31/2024	4,005,702	528,285	585,386	596,730	22
6/30/2024	3,631,085	653,214	206,972	337,367	N/A
3/31/2024	3,671,719	143,850	240,058	391,213	N/A
12/31/2023	3,673,964	152,522	174,760	348,228	N/A
9/30/2023	3,835,683	161,010	220,194	384,674	N/A
6/30/2023	3,883,262	157,219	283,188	453,528	N/A
3/31/2023	3,883,600	104,331	144,221	295,120	N/A
12/31/2022	4,134,933	134,475	16,101	151,024	N/A
9/30/2022	4,371,912	68,371	188,035	308,918	N/A
6/30/2022	4,544,441	84,039	240,729	357,734	N/A
3/31/2022	4,775,375	175,913	439,916	561,718	N/A
12/31/2021	4,863,128	193,681	570,824	691,434	N/A
9/30/2021	4,695,327	178,982	466,452	600,030	N/A
6/30/2021	4,675,027	148,728	498,866	651,475	N/A
3/31/2021	4,554,106	98,653	396,239	568,723	N/A
12/31/2020	4,432,179	35,132	339,700	554,359	N/A
9/30/2020	4,608,908	42,912	305,944	549,921	N/A
6/30/2020	4,922,270	137,275	363,995	625,898	N/A
3/31/2020	5,259,669	186,991	348,156	624,370	N/A
12/31/2019	5,580,142	238,804	439,375	718,301	N/A
9/30/2019	5,470,617	289,696	354,956	637,397	N/A
6/30/2019	5,347,037	234,594	124,318	483,115	N/A
3/31/2019	5,297,581	282,385	144,227	574,725	N/A
12/31/2018	5,277,845	332,195	191,031	646,677	N/A
9/30/2018	5,193,657	347,563	-27,746	604,822	N/A
6/30/2018	5,125,097	377,054	-134,015	618,357	N/A
3/31/2018	4,986,371	347,115	N/A	444,561	N/A
12/31/2017	5,123,826	394,011	N/A	512,563	N/A
9/30/2017	5,299,895	450,531	N/A	537,348	N/A
6/30/2017	5,490,953	488,541	N/A	615,218	N/A
3/31/2017	5,729,430	600,383	N/A	678,329	N/A
12/31/2016	5,645,440	639,255	N/A	676,952	N/A
9/30/2016	5,555,181	636,268	N/A	696,200	N/A
6/30/2016	5,295,359	658,995	N/A	628,452	N/A
3/31/2016	5,047,329	628,616	N/A	690,384	N/A
12/31/2015	4,766,627	577,523	N/A	627,504	N/A
9/30/2015	4,519,611	550,538	N/A	636,223	N/A
6/30/2015	4,375,235	515,495	N/A	686,149	N/A
3/31/2015	4,146,542	466,286	N/A	682,951	N/A
12/31/2014	3,874,008	379,104	N/A	586,111	N/A
9/30/2014	3,600,095	373,665	N/A	558,426	N/A
6/30/2014	3,396,154	335,996	N/A	475,093	N/A
3/31/2014	3,228,442	298,132	N/A	445,513	N/A
12/31/2013	3,100,413	267,975	N/A	426,657	N/A
9/30/2013	3,043,461	257,412	N/A	370,498	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: A090430's earnings are forecast to decline over the next 3 years (-12.5% per year).

Earnings vs Market: A090430's earnings are forecast to decline over the next 3 years (-12.5% per year).

High Growth Earnings: A090430's earnings are forecast to decline over the next 3 years.

Revenue vs Market: A090430's revenue (13.5% per year) is forecast to grow faster than the KR market (10.7% per year).

High Growth Revenue: A090430's revenue (13.5% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: A090430's Return on Equity is forecast to be low in 3 years time (8%).

Amorepacific Future Growth

Future criteria checks 1/6

Key information

Recent future growth updates

Consensus EPS estimates increase by 51%, revenue downgraded

Consensus EPS estimates increase by 11%

Price target increased by 13% to ₩183,958

Consensus EPS estimates fall by 10%

Price target increased by 8.0% to ₩151,000

Consensus EPS estimates fall by 10%

Recent updates

New major risk - Revenue and earnings growth

Amorepacific Corporation's (KRX:090430) Share Price Is Still Matching Investor Opinion Despite 26% Slump

Amorepacific (KRX:090430) Seems To Use Debt Rather Sparingly

New minor risk - Share price stability

Consensus EPS estimates increase by 51%, revenue downgraded

Investor sentiment deteriorates as stock falls 32%

Now 29% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 16%

Now 21% undervalued

Is Amorepacific Corporation (KRX:090430) Potentially Undervalued?

A Look At The Intrinsic Value Of Amorepacific Corporation (KRX:090430)

Consensus EPS estimates increase by 11%

Investor sentiment improves as stock rises 19%

Price target increased by 13% to ₩183,958

Be Wary Of Amorepacific (KRX:090430) And Its Returns On Capital

Amorepacific Corporation (KRX:090430) Looks Just Right With A 26% Price Jump

Now 22% overvalued after recent price rise

Amorepacific (KRX:090430) Has A Pretty Healthy Balance Sheet

Amorepacific's (KRX:090430) Profits May Not Reveal Underlying Issues

Full year 2023 earnings released: EPS: ₩2,609 (vs ₩1,949 in FY 2022)

Amorepacific Corporation, Annual General Meeting, Mar 15, 2024

Amorepacific Corporation, Annual General Meeting, Mar 15, 2024

Amorepacific Unveils Research Demonstrating the Impact of Lymphatic Activating Ingredients

Now 22% overvalued after recent price rise

Upcoming dividend of ₩680 per share at 0.5% yield

New minor risk - Earnings quality

Investor sentiment improves as stock rises 26%

Consensus EPS estimates fall by 10%

Price target increased by 8.0% to ₩151,000

Amorepacific Corporation (KOSE:A090430) agreed to acquire additional 54.8% stake in Cosrxinc Co., Ltd. for approximately KRW 760 billion.

New major risk - Revenue and earnings growth

Consensus EPS estimates fall by 10%

Investor sentiment deteriorates as stock falls 15%

Full year 2022 earnings released: EPS: ₩1,949 (vs ₩2,820 in FY 2021)

Price target increased to ₩145,524

Upcoming dividend of ₩980 per share

Amorepacific and BTS Collaborate to Release Limited-Edition Set Featuring NEW "Butter" Lip Sleeping Mask Flavor

No independent directors

Consensus EPS estimates fall by 11%

Now 24% undervalued after recent price drop

Price target decreased to ₩132,833

Amorepacific Corporation (KOSE:A090430) entered into an agreement to acquire Tata's Natural Alchemy, LLC from Alliance Consumer Growth, LLC and M13 Ventures Management, LLC for WON 168.1 billion.

Price target decreased to ₩171,950

Amorepacific Corporation Develops First Chip-Less Wireless Electronic Skin Enabled by Semiconductors

Price target decreased to ₩180,150

Amorepacific Corporation Ordinary Shares to Be Deleted from OTC Equity

No independent directors

Investor sentiment improved over the past week

Upcoming dividend of ₩800 per share

Amorepacific Introduces Special Collaboration with BTS

Consensus EPS estimates fall to ₩7,087

Price target increased to ₩282,793

Price target increased to ₩268,464

Amorepacific (KRX:090430) Seems To Use Debt Quite Sensibly

Full year 2020 earnings released: EPS ₩512 (vs ₩3,477 in FY 2019)

Did You Miss Amorepacific's (KRX:090430) 41% Share Price Gain?

Does Amorepacific's (KRX:090430) Statutory Profit Adequately Reflect Its Underlying Profit?

Price target raised to ₩228,500

Amorepacific Corporation (KRX:090430) Shares Could Be 30% Above Their Intrinsic Value Estimate

Amorepacific Corporation to Report Fiscal Year 2020 Results on Feb 03, 2021

Analysts update estimates

Analysts update estimates

The Trends At Amorepacific (KRX:090430) That You Should Know About

New 90-day high: ₩220,500

Analysts update estimates

Amorepacific Corporation's (KRX:090430) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?

Is Amorepacific Corporation (KRX:090430) An Attractive Dividend Stock?

New 90-day high: ₩217,000

Amorepacific (KRX:090430) Seems To Use Debt Quite Sensibly